Atezolizumab with carboplatin and etoposide for untreated extensive-stage small-cell lung cancer

Final draft guidance

Final appraisal document (PDF 260 KB)

Draft guidance

Appraisal consultation document (PDF version) (PDF 278 KB)

Committee papers (PDF 5.49 MB)

Public committee slides (PDF 1.11 MB)

Final scope (PDF 228 KB)

Provisional Stakeholder List (post-referral) (PDF 339 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 292 KB)

Draft scope post referral (PDF 315 KB)